Clinical Trial Update: Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial of pegylated liposomal doxorubicin and cyclophosphamide with or without trastuzumab, followed by docetaxel, in breast cancer. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Doxil (liposomal doxorubicin)
• HERCEPTIN (trastuzumab)
• Taxotere (docetaxel)

Snippet

Sponsor: Herlev Hospital | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED